Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2023-04-13 00:00:00 ET · period of report 2023-04-11 · accession 0001209191-23-024205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-13 | 2023-04-11 | TVTX | Cline Christopher R. | CFO | S - Sale | $21.49 | -47 | 51.5K | -0.1% | -$1,010 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-11 | S | D | 47 | $21.49 | 51,486 | D | — | — |